Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine



   conn syndrome
  

Disease ID 770
Disease conn syndrome
Definition
overproduction of aldosterone by an adrenal cortical adenoma, characterized typically by low potassium levels, underacidity of the body, muscular weakness, excess urination, excess thirst, and high blood pressure.
Synonym
aldosteronism primary
aldosteronism, primary
conn's syndrome
conns syndrome
hyperaldosteronism, primary
idiopathic aldosteronism
idiopathic aldosteronism (disorder)
idiopathic hyperaldosteronism
primary aldosteronism
primary aldosteronism (disorder)
primary aldosteronism (disorder) [ambiguous]
primary hyperaldosteronism
primary hyperaldosteronism (disorder)
syndrome, conn
syndrome, conn's
DOID
ICD10
UMLS
C1384514
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:41)
C0020538  |  hypertension  |  24
C0001430  |  adenoma  |  7
C0221002  |  primary hyperparathyroidism  |  6
C0206667  |  adrenal adenoma  |  5
C0334684  |  renal adenoma  |  5
C0020502  |  hyperparathyroidism  |  5
C0155616  |  secondary hypertension  |  5
C1621895  |  adrenal hyperplasia  |  5
C0010481  |  cushing's syndrome  |  4
C0018801  |  heart failure  |  2
C0022661  |  chronic kidney disease  |  2
C0020428  |  aldosteronism  |  2
C0206667  |  adrenocortical adenoma  |  2
C0948265  |  metabolic syndrome  |  2
C0001621  |  adrenal disease  |  1
C1384514  |  primary aldosteronism  |  1
C0024586  |  carcinoid syndrome  |  1
C0020428  |  hyperaldosteronism  |  1
C0085413  |  autosomal dominant polycystic kidney disease  |  1
C0010481  |  cushing syndrome  |  1
C0022679  |  cystic kidney  |  1
C1565489  |  renal insufficiency  |  1
C0027709  |  nephrocalcinosis  |  1
C0206686  |  adrenocortical carcinoma  |  1
C0085413  |  autosomal dominant polycystic kidney  |  1
C0023895  |  liver disease  |  1
C1142166  |  brugada syndrome  |  1
C0033687  |  proteinuria  |  1
C0085580  |  essential hypertension  |  1
C0206667  |  adrenocortical adenomas  |  1
C1370740  |  adrenal carcinoma  |  1
C0022658  |  kidney disease  |  1
C0037315  |  sleep apnea  |  1
C0677607  |  hashimoto's thyroiditis  |  1
C0022658  |  renal disease  |  1
C0917996  |  cerebral aneurysm  |  1
C0001206  |  acromegaly  |  1
C0011847  |  diabetes  |  1
C0007134  |  renal carcinoma  |  1
C0020540  |  malignant hypertension  |  1
C0011849  |  diabetes mellitus  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:3)
1584  |  CYP11B1  |  UNIPROT
1585  |  CYP11B2  |  UNIPROT
8912  |  CACNA1H  |  CLINVAR
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:1)
1585  |  CYP11B2  |  CIPHER
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:64)
79611  |  ACSS3  |  2.489  |  DISEASES
101  |  ADAM8  |  1.099  |  DISEASES
9370  |  ADIPOQ  |  1.276  |  DISEASES
183  |  AGT  |  2.03  |  DISEASES
279  |  AMY2A  |  1.377  |  DISEASES
64333  |  ARHGAP9  |  2.01  |  DISEASES
444  |  ASPH  |  2.995  |  DISEASES
480  |  ATP1A4  |  5.65  |  DISEASES
10159  |  ATP6AP2  |  1.226  |  DISEASES
551  |  AVP  |  1.058  |  DISEASES
153571  |  C5orf38  |  2.734  |  DISEASES
8912  |  CACNA1H  |  3.669  |  DISEASES
57118  |  CAMK1D  |  1.21  |  DISEASES
1188  |  CLCNKB  |  1.408  |  DISEASES
1499  |  CTNNB1  |  2.172  |  DISEASES
1585  |  CYP11B2  |  6.68  |  DISEASES
1586  |  CYP17A1  |  3.866  |  DISEASES
1589  |  CYP21A2  |  2.141  |  DISEASES
1555  |  CYP2B6  |  2.248  |  DISEASES
1733  |  DIO1  |  1.27  |  DISEASES
1906  |  EDN1  |  1.865  |  DISEASES
2128  |  EVX1  |  1.888  |  DISEASES
2868  |  GRK4  |  2.389  |  DISEASES
9464  |  HAND2  |  1.034  |  DISEASES
100316868  |  HOTTIP  |  1.355  |  DISEASES
285943  |  HOXA-AS2  |  2.201  |  DISEASES
3283  |  HSD3B1  |  2.97  |  DISEASES
3284  |  HSD3B2  |  2.914  |  DISEASES
3360  |  HTR4  |  2.014  |  DISEASES
3635  |  INPP5D  |  1.103  |  DISEASES
3645  |  INSRR  |  2.593  |  DISEASES
3762  |  KCNJ5  |  6.474  |  DISEASES
3775  |  KCNK1  |  1.393  |  DISEASES
8645  |  KCNK5  |  2.24  |  DISEASES
3778  |  KCNMA1  |  1.155  |  DISEASES
22944  |  KIN  |  1.388  |  DISEASES
9622  |  KLK4  |  3.592  |  DISEASES
126364  |  LRRC25  |  1.311  |  DISEASES
4158  |  MC2R  |  2.758  |  DISEASES
4221  |  MEN1  |  2.3  |  DISEASES
8972  |  MGAM  |  1.031  |  DISEASES
4311  |  MME  |  2.048  |  DISEASES
4702  |  NDUFA8  |  2.43  |  DISEASES
255743  |  NPNT  |  1.654  |  DISEASES
4878  |  NPPA  |  3.079  |  DISEASES
190  |  NR0B1  |  1.784  |  DISEASES
4306  |  NR3C2  |  5.641  |  DISEASES
3164  |  NR4A1  |  1.453  |  DISEASES
4929  |  NR4A2  |  2.83  |  DISEASES
2516  |  NR5A1  |  1.913  |  DISEASES
5575  |  PRKAR1B  |  2.423  |  DISEASES
389362  |  PSMG4  |  2.446  |  DISEASES
6338  |  SCNN1B  |  2.415  |  DISEASES
6559  |  SLC12A3  |  2.312  |  DISEASES
57419  |  SLC24A3  |  1.761  |  DISEASES
1811  |  SLC26A3  |  1.168  |  DISEASES
8859  |  STK19  |  1.624  |  DISEASES
8428  |  STK24  |  1.454  |  DISEASES
27347  |  STK39  |  1.521  |  DISEASES
6898  |  TAT  |  1.156  |  DISEASES
10732  |  TCFL5  |  1.334  |  DISEASES
10178  |  TENM1  |  1.165  |  DISEASES
7539  |  ZFP37  |  2.534  |  DISEASES
653808  |  ZG16  |  2.965  |  DISEASES
Locus(Waiting for update.)
Disease ID 770
Disease conn syndrome
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:42)
HP:0000822  |  Hypertension  |  27
HP:0008221  |  Enlarged adrenal glands  |  7
HP:0008200  |  Primary hyperparathyroidism  |  6
HP:0002900  |  Hypokalemia  |  5
HP:0000843  |  Hyperparathyroidism  |  5
HP:0001712  |  Left ventricular hypertrophy  |  4
HP:0001714  |  Ventricular hypertrophy  |  4
HP:0001685  |  Myocardial fibrosis  |  4
HP:0006744  |  Adrenal carcinoma  |  2
HP:0012622  |  Chronic kidney disease  |  2
HP:0000121  |  Nephrocalcinosis  |  2
HP:0003470  |  Inability to move  |  2
HP:0008256  |  Adrenocortical adenomas  |  2
HP:0000859  |  Mineralocorticoid excess  |  2
HP:0002664  |  Neoplasia  |  2
HP:0001635  |  Congestive heart failure  |  2
HP:0001578  |  Hypercortisolism  |  1
HP:0000834  |  Adrenal abnormalities  |  1
HP:0000845  |  Acromegalic growth  |  1
HP:0002170  |  Intracranial hemorrhage  |  1
HP:0000872  |  Hashimoto's thyroiditis  |  1
HP:0002617  |  Aneurysmal dilatation  |  1
HP:0008231  |  Macronodular adrenal hyperplasia  |  1
HP:0002104  |  Absence of spontaneous respiration  |  1
HP:0004944  |  Cerebral artery aneurysm  |  1
HP:0001324  |  Muscular weakness  |  1
HP:0002140  |  Ischemic stroke  |  1
HP:0010535  |  Sleep apnea  |  1
HP:0000093  |  Proteinuria  |  1
HP:0012408  |  Medullary nephrocalcinosis  |  1
HP:0005584  |  Renal cell carcinoma  |  1
HP:0000083  |  Renal insufficiency  |  1
HP:0001250  |  Seizures  |  1
HP:0011675  |  Arrhythmias  |  1
HP:0000113  |  Polycystic kidney dysplasia  |  1
HP:0001297  |  Cerebral vascular events  |  1
HP:0030731  |  Carcinoma  |  1
HP:0100570  |  Carcinoid tumor  |  1
HP:0000819  |  Diabetes mellitus  |  1
HP:0003201  |  Rhabdomyolysis  |  1
HP:0001664  |  Torsade de pointes  |  1
HP:0004308  |  Ventricular arrhythmia  |  1
Disease ID 770
Disease conn syndrome
Manually Symptom
UMLS  | Name(Total Manually Symptoms:3)
C1609519  |  adrenal myelolipoma
C0206667  |  adrenal cortex adenoma
C0206635  |  myelolipoma
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:21)
C0020538  |  hypertension  |  27
C0221002  |  primary hyperparathyroidism  |  6
C0001430  |  adenoma  |  6
C0206667  |  adrenal adenoma  |  5
C0155616  |  secondary hypertension  |  3
C0948265  |  metabolic syndrome  |  3
C2062372  |  bilateral adrenal hyperplasia  |  3
C0027709  |  nephrocalcinosis  |  2
C0020428  |  hyperaldosteronism  |  2
C0001624  |  adrenal tumor  |  2
C1393529  |  vascular complications  |  1
C0427008  |  stiffness  |  1
C0004093  |  weakness  |  1
C1609519  |  adrenal myelolipoma  |  1
C0001621  |  adrenal disease  |  1
C0023895  |  liver disease  |  1
C0020540  |  malignant hypertension  |  1
C0011847  |  diabetes  |  1
C0206667  |  adrenocortical adenomas  |  1
C0011849  |  diabetes mellitus  |  1
C0264641  |  endocrine hypertension  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
Text Mining Genotype(Total Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:8)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs151052374112759501585CYP11B2umls:C1384514BeFreeIn this study we investigated the presence of the mutation D147E of CYP11B2 in a group of 128 patients with primary aldosteronism, 68 patients with essential hypertension and increased corticosterone production and in 48 normal volunteers.0.0091530792001CYP11B2;GML8142915200AT
rs1799998115871615972RENumls:C1384514BeFreeThe aim of the study was to investigate allele and genotype frequencies of the -344C/T polymorphism, located in the promoter region of the aldosterone synthase gene, in 83 patients with idiopathic low renin hypertension characterized by an increased aldosterone to renin ratio, including both patients with low renin essential hypertension (n=53) and subjects with idiopathic hyperaldosteronism (n=30), compared with 78 patients with normal to high renin essential hypertension and 126 normotensive control subjects.0.0073289312001CYP11B2;LOC1053757938142918184AG
rs1799998121072461585CYP11B2umls:C1384514BeFreeThe aim of our study was to identify genetic variants that influence the phenotype of patients with PA. We hypothesized that genetic variants potentially affecting aldosterone production (aldosterone synthase, CYP11B2), renal proximal tubule reabsorption (alpha-adducin), or the mechanisms of counterbalance leading to vasodilatation and sodium excretion (bradykinin B(2)-receptor, B(2)R) could influence the clinical and biochemical characteristics of patients with PA. We studied three polymorphisms of these genes (C-344T of CYP11B2, G460W of alpha-adducin, and C-58T of B(2)R) in 167 primary aldosteronism patients (56 with aldosterone-producing adenoma and 111 with idiopathic hyperaldosteronism).0.0091530792002CYP11B2;LOC1053757938142918184AG
rs1799998115871611585CYP11B2umls:C1384514BeFreeThe aim of the study was to investigate allele and genotype frequencies of the -344C/T polymorphism, located in the promoter region of the aldosterone synthase gene, in 83 patients with idiopathic low renin hypertension characterized by an increased aldosterone to renin ratio, including both patients with low renin essential hypertension (n=53) and subjects with idiopathic hyperaldosteronism (n=30), compared with 78 patients with normal to high renin essential hypertension and 126 normotensive control subjects.0.0091530792001CYP11B2;LOC1053757938142918184AG
rs2241766194819139370ADIPOQumls:C1384514BeFreeGenetic analysis of T45G and G276T adiponectin gene polymorphisms showed that, while the genotypes 45G/G+G/T seemed to have a protective role on the metabolic complications, the genotype 276T/T defined PA and EH patients with a worse metabolic profile.0.0008143262010ADIPOQ;ADIPOQ-AS13186853103TG
rs2241766235906059370ADIPOQumls:C1384514BeFreeT45G and G276T adiponectin gene polymorphisms in primary aldosteronism and healthy controls in an East Slovak population.0.0008143262014ADIPOQ;ADIPOQ-AS13186853103TG
rs2604204233828653762KCNJ5umls:C1384514BeFreeThe genetic variant rs2604204 of KCNJ5 is associated with sporadic PA in Chinese males, suggesting that KCNJ5 may be involved in the pathogenesis of sporadic PA in these particular patients.0.0051573962013KCNJ511128917535GT
rs786205050NA8912CACNA1Humls:C1384514CLINVARNA0.120542884NACACNA1H161212024AG
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Disease ID 770
Disease conn syndrome
Case(Waiting for update.)